Consolidated Statement of Operations - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Details
Revenues	$ 1,483,960	$ 1,509,808	$ 4,340,577	$ 4,669,573
Operating expenses
Cost of revenues	1,227,394	579,491	3,111,778	1,714,615
Research and development expenses	91,050	55,802	247,977	156,685
Selling, general, and administrative expenses	1,353,213	672,399	3,441,903	1,987,183
Operating Expenses	2,671,657	1,307,692	6,801,658	3,858,483
Income/(Loss) from operations	(1,187,697)	202,116	(2,461,081)	811,090
Interest expense - related party	301,608	266,400	832,762	790,513
Income/(Loss) before income taxes	(1,489,305)	(64,284)	(3,293,843)	20,577
Provision for income taxes	0	0	0	0
Net Income/(Loss)	$ (1,489,305)	$ (64,284)	$ (3,293,843)	$ 20,577
Net income/(loss) per common share - basic	$ (0.19)	$ (0.01)	$ (0.43)	$ 0.00
Net income/(loss) per common share - diluted	$ (0.19)	$ (0.01)	$ (0.43)	$ 0.00
Weighted average number of common shares outstanding - basic	7,712,091	7,712,091	7,712,091	7,712,091
Weighted average number of common shares outstanding - diluted	7,712,091	7,712,091	7,712,091	7,748,451